| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |
| I863187 | MACKLIN | 伊布利特半富马酸盐 | ≥98%(HPLC)(N) | 398元/100mg; | 咨询 |
|
| I794410 | MACKLIN | 伊布利特半富马酸盐 | 10mM in DMSO | 470元/1ml; | 咨询 |
|
| I0946 | TCI | Ibutilide Hemifumarate | >98.0%(HPLC)(N) | 535元/20MG; 1790元/100MG; | 咨询 |
基本信息 | 纯度/分析方法 | >98.0%(HPLC)(N) | | 分子式/分子量 | C20H36N2O3S・^^1/2C4H4O4 = 442.62 | | 外观与形状(20℃) | 固体 | | 相关CAS RN | 122647-31-8 | | PubChem物质ID | 253662069 | | Merck Index (14) | 4883 | | MDL编号 | MFCD01715410 |
技术规格 | Appearance | White to Almost white powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(with Total Nitrogen) | min. 98.0 % |
物性(参考值) 安全信息 | 图形或危害标志 |  | | 信号词 | 警告 | | 危险性说明 | H302 : 吞咽有害。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。
P270 : 使用本产品时不要进食、饮水或吸烟。
P264 : 作业后彻底清洗皮肤。
P301 + P312 + P330 : 如误吞咽：如感觉不适，呼叫急救中心/医生。漱口。
|
相关法规 |
| H56358 | Alfa Aesar | Ibutilide hemifumarate salt | 99% | 3464元/25mg; 12500元/100mg; | 咨询 |
基本信息 MDL
MFCD01715410 分子式
C20H36N2O3S?0.5C4H4O4 分子量
442.61 形态
Solid Merck
14,4883 GHS危害和防范说明 GHS符号
Hazard Statements
H302
Harmful if swallowed. Precautionary Statements
P264-P270-P301+P312a-P330-P501a
Wash thoroughly after handling.Do not eat, drink or smoke when using this product.Do not eat, drink or smoke when using this product.Rinse mouth.Dispose of contents/container in accordance with local/regional/national/international regulations. 安全信息 危险类别
22
Harmful if swallowed. 安全等级
36-60
Wear suitable protective clothing.This material and its container must be disposed of as hazardous waste 欧盟危险品标志
 RTECS
PB0475700 TSCA
否 |
| I9910 | Sigma-Aldrich | Ibutilide hemifumarate salt | ≥98% (HPLC) | 1714.02元/10 MG; 4984.72元/50 MG; | 咨询 |
产品说明 包装 10, 50 mg in glass bottle 生化/生理作用 Ibutilide hemifumarate salt is considered a new generation "pure" Class III antiarrhythmic agent. Ibutilide binds to and alters the activity of hERG potassium channels, delayed inward rectifier potassium (IKr) channels and L-type (dihydropyridine sensitive) calcium channels. 特点和优势 This compound was developed by Pfizer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here. 基本信息 | 经验(实验)分子式 | C20H36N2O3S · 0.5C4H4O4 | | 分子量 | 442.61 | | MDL编号 | MFCD01715410 | | PubChem化学物质编号 | 329815470 | | NACRES | NA.77 |
产品性质 | 质量水平 | 100 | | 测定 | ≥98% (HPLC) | | 形式 | solid | | 颜色 | off-white to tan | | 溶解性 | H2O: >20 mg/mL | | 创始人 | Pfizer | | 储存温度 | room temp | | SMILES string | OC(=O)\C=C\C(O)=O.CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1.CCCCCCCN(CC)CCCC(O)c2ccc(NS(C)(=O)=O)cc2 | | InChI | 1S/2C20H36N2O3S.C4H4O4/c2*1-4-6-7-8-9-16-22(5-2)17-10-11-20(23)18-12-14-19(15-13-18)21-26(3,24)25;5-3(6)1-2-4(7)8/h2*12-15,20-21,23H,4-11,16-17H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+ | | InChI key | PCIOHQNIRPWFMV-WXXKFALUSA-N | | Gene Information | human ... KCNH2(3757) |
安全信息 | 象形图 |  | | 警示用语： | Warning | | 危险声明 | H302 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P312 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Repr. 2 | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 1 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1335610 | USP | Ibutilide fumarate | United States Pharmacopeia (USP) Reference Standard, monograph mol wt. 885.23 ([(C20H36N2O3S)2 . C4H4O4| 9048.14元/100 MG; | 咨询 | |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 Ibutilide hemifumarate salt is considered a new generation "pure" Class III antiarrhythmic agent. Ibutilide binds to and alters the activity of hERG potassium channels, delayed inward rectifier potassium (IKr) channels and L-type (dihydropyridine sensitive) calcium channels. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here.
Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C20H36N2O3S · 0.5C4H4O4 | | 分子量 | 442.61 | | MDL编号 | MFCD01715410 | | PubChem化学物质编号 | 329750146 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | 分子量 | monograph mol wt. 885.23 ([(C20H36N2O3S)2 . C4H4O4]) | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | OC(=O)\C=C\C(O)=O.CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1.CCCCCCCN(CC)CCCC(O)c2ccc(NS(C)(=O)=O)cc2 | | InChI | 1S/2C20H36N2O3S.C4H4O4/c2*1-4-6-7-8-9-16-22(5-2)17-10-11-20(23)18-12-14-19(15-13-18)21-26(3,24)25;5-3(6)1-2-4(7)8/h2*12-15,20-21,23H,4-11,16-17H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+ | | InChI key | PCIOHQNIRPWFMV-WXXKFALUSA-N | | Gene Information | human ... KCNH2(3757) |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 - H361d | | 预防措施声明 | P202 - P264 - P270 - P280 - P301 + P312 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Repr. 2 | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 1 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
m.cnreagent.com